“…71 In this context, a total of 14 in vivo studies dealing with NLRP3 inflammasome modulation in T2D by polyphenols were identified, as shown in Table 3. [72][73][74][75][76][77][78][79][80][81][82][83][84][85] All of them were preclinical studies, with streptozotocin (STZ)-induced T2D as the most common one. In particular, 9 of the identified studies used this approach, with diabetic nephropathy 72,74,75,82 being the most studied diabetic complication, but with other studies focused on diabetic retinopathy, 77 diabetic cardiomyopathy, 78,85 diabetic neuropathic pain, 80 and atherosclerosis in a diabetic context.…”